Discovery and Basic Research - Medicinal Chemistry

(M0930-05-26) Distinguishing Tobacco-Derived Nicotine from Synthetic Nicotine in Commercial Nicotine Samples

(W1030-05-26) Studying the Effect of Increased Modifier Range on EPSA Analysis by SFC

(T1130-05-26) Developing a Dual Prodrug for Triggered Antibiotic Activation

(M1130-05-26) Hit to Lead Optimization Studies of Meta Substituted Enaminone Derivatives as Potential Anti-Seizure Agents for Generalized and Drug-Resistant Epilepsy

(M1330-05-26) The Cationic Antimicrobial Peptide, D-LAK-120A, as a Potential Anti-cancer Therapeutic for Non-small Cell Lung Cancer (NSCLC)

(T1430-10-56) Increasing the Productivity of Oligonucleotide Purification through Column Scaling and Method Optimization